Trial ID or NCT#





FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Official Title

Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma

Eligibility Criteria

Ages Eligible for Study: 18 Years to 90 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Nielsen Fernandez-Becker, MD, PhD
Gastroenterologist, Celiac disease specialist, Motility specialist
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
John O'Brien Clarke, MD
Gastroenterologist, Motility specialist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Lorinda Chung MD MS
Rheumatologist, Immunologist
Associate Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology at the Palo Alto Veterans Affairs Health Care Center

Contact us to find out if this trial is right for you.


John O Clarke, MD
(650) 736-5555